At the completion of this educational session, participants should be able to:
- Know the patient and graft outcomes among 150 HIV-positive kidney recipients followed prospectively, including the challenges with transplant rejection and management of drug interactions and potential nephrotoxicities.
- Understand predictors of mortality and implications for patient selection among 125 HIV-positive liver transplant recipients.
- Discuss HIV-specific outcomes and predictors among the entire cohort of 275 HIV-positive liver and kidney recipients, all followed for a minimum of 1 year.
Michelle Roland is Chief of the Office of AIDS, for the California Department of Health, and Associate Clinical
Professor of Medicine in the Department of Medicine, UCSF Positive Health Program (HIV/AIDS Division) at San
Francisco General Hospital. In addition to her leadership in non-occupational post-exposure prophylaxis research,
Dr Roland developed and implemented pilot studies that led to an NIH-funded, 21-center study of kidney and
liver transplantation in people living with HIV, for which she served as co-principle investigator and lead HIV
To obtain CME credit for this and other PRN programs, please visit the PRN Video Channel
at the Clinical Education Initiative (CEI) web site http://www.ceitraining.org/prn-video/. PRN and the Medical Society of the State of New York (MSSNY) jointly sponsor PRN enduring materials for CME, and provide them at no cost to the AIDS Institute of the New York State Department of Health (NYSDOH) for broadcast through the CEI. We thank the NYSDOH for making our CME programs available to a wider audience, and hope you will also browse the many other educational opportunities offered by the CEI.